Vital Sign Comparison Between Lifelight and Standard of Care - Development
NCT ID: NCT04003662
Last Updated: 2021-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
9000 participants
OBSERVATIONAL
2018-05-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Measurement of VItal SIgns by Lifelight® Software in comparisON to the Standard of Care - Multi-site Development
NCT04763746
The VISION-Acute Study
NCT04589923
A Single Center Study to Demonstrate the Safety and Performance of Lifelight® First Software Application
NCT03998098
The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III
NCT02973243
Video Vitals and Biomarkers
NCT06136156
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this research study is to improve the accuracy of the LifeLight system with a view to a subsequent Validation study to prove the level of accuracy. The investigators will recruit patients, staff and visitors, both with and without medical problems, and take vital sign measurements twice with normal equipment and while recording video data at the same time. This will allow the AI which develops the LifeLight algorithm to make it more accurate, prior to a subsequent study which will validate the results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inpatients
Vital signs measurement - standard of care and prototype
Vital Signs Measurement
Vital signs are measured twice with standard of care equipment while recording digital video data at the same time.
outpatients
Vital signs measurement - standard of care and prototype
Vital Signs Measurement
Vital signs are measured twice with standard of care equipment while recording digital video data at the same time.
Healthy controls
Vital signs measurement - standard of care and prototype
Vital Signs Measurement
Vital signs are measured twice with standard of care equipment while recording digital video data at the same time.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vital Signs Measurement
Vital signs are measured twice with standard of care equipment while recording digital video data at the same time.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* I2. Able and willing to comply with all study requirements.
* I3. Able and willing to provide written informed consent to participate (including by parent or legal guardian if under 16 years old).
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xim Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Portsmouth Hospitals NHS Trust
Portsmouth, England, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHT/2018/25 IRAS ID 242581
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.